Brief: Dermapharm Q1 Adj. EBITDA Up 28.9% At EUR 63.7 Mln

Dermapharm Holding SE

18/05/2021 06:38

May 18 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * ACCELERATED EBITDA GROWTH IN Q1 2021
    * Q1 ADJUSTED EBITDA ROSE 28.9 PERCENT TO 63.7 MILLION EUR
    * Q1 REVENUE ROSE 10.2 PERCENT TO 212.2 MILLION EUR
    * Q1 CONSOLIDATED REVENUE UP 10.2% TO EUR 212.2 MILLION
    * Q1 ADJUSTED CONSOLIDATED EBITDA RISES 28.9% TO EUR 63.7
MILLION
    * BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR 2021 OVERALL

Source text for Eikon:  ID:nEQ6gy2pka 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))